January 14, 2025

Shortages Continue in Access to Ophthalmic Subspecialties in Rural Populations

Only 5.6% of surgeons practiced in rural areas, compared to 17.4% of patients residing rurally.

Conexiant

January 14, 2025

Comparative Analysis Ranks Mediterranean Diet for Prediabetes

"The good news is that lifestyle changes can cut Type 2 diabetes risk in half."

Conexiant

December 23, 2024

Hyperglycemia Confirmed as Dominant Risk Factor for Retinopathy

Higher body mass index and hypertension should also be managed to reduce risk.

Conexiant

December 23, 2024

Pathogenesis and Future Immunotherapy Treatment Directions for Uveitis, DR, AMD, and Graves’ Ophthalmopathy

An overview of the roles of immune cells, cytokines, and signaling pathways for these diseases.

Conexiant

December 20, 2024

Empagliflozin Reduces Risk of Diabetic Retinopathy Progression

Investigators found a 22% reduced risk of progression in patients with preexisting NPDR.

Conexiant

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant

July 03, 2024

Semaglutide Linked to Vision-Threatening Eye Disorder

New study finds that 8.9% of type 2 diabetes patients taking semaglutide experienced NAION, compared to 1.8% of those on non-GLP-1 diabetes drugs.

Reuters

November 07, 2024

Diabetes Affects 1 in 6 US Adults: CDC Data

In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals.

Conexiant

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters